Life ScienceCompany
Virdante Pharmaceuticals - Sialic Switch Assets Ownership
Who owns Virdante Pharmaceuticals - Sialic Switch Assets?
Virdante Pharmaceuticals - Sialic Switch Assets is owned by Momenta Pharmaceuticals. It was acquired on December 5, 2011.
Virdante Pharmaceuticals - Sialic Switch Assets Business Overview
Where is Virdante Pharmaceuticals - Sialic Switch Assets headquartered?
Virdante Pharmaceuticals - Sialic Switch Assets is headquartered in United States.
What sector is Virdante Pharmaceuticals - Sialic Switch Assets in?
Virdante Pharmaceuticals - Sialic Switch Assets is a life science company.
Life Science M&A Summary in 2011
Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.
Join Mergr to view all 172 acquisitions of life science companies in 2011, including 23 acquisitions by private equity firms, and 149 by strategics.